Raphael Pharmaceutical (RAPH) Shares Outstanding (Entity) (2020 - 2025)
Raphael Pharmaceutical (RAPH) Shares Outstanding (Entity) (2020 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.67 Bn | 17.78 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 834.66 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 20.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.18 Mn |
| Sep 30, 2025 | 19.63 Mn |
| Jun 30, 2025 | 19.63 Mn |
| Mar 31, 2025 | 19.63 Mn |
| Dec 31, 2024 | 18.70 Mn |
| Sep 30, 2024 | 18.70 Mn |
| Jun 30, 2024 | 18.70 Mn |
| Mar 31, 2024 | 18.66 Mn |
| Dec 31, 2023 | 18.50 Mn |
| Sep 30, 2023 | 18.10 Mn |
| Jun 30, 2023 | 16.37 Mn |
| Mar 31, 2023 | 16.00 Mn |
| Dec 31, 2022 | 15.62 Mn |
| Sep 30, 2022 | 15.48 Mn |
| Jun 30, 2022 | 14.23 Mn |
| Mar 31, 2022 | 13.29 Mn |
| Dec 31, 2021 | 12.97 Mn |
| Sep 30, 2021 | 12.14 Mn |
| Jun 30, 2021 | 12.05 Mn |
| Mar 31, 2021 | 9.46 Mn |